In FY 2020, the percentage of case shipments were up by +15% YoY. During the current FY, this KPIs is expected to grow double-digits sequentially. In terms of consumer shift, both channel partners as well as private clinics continue to occupy the centerstage in the company’s revenue mix.
The rising consolidation and emergence of group practices focused on high-margin treatment areas such as orthodontic and cosmetic treatments have further propelled Angelalign Technology’s business.
As continued efforts of the company’s growth strategy, Angelalign Technology expects to deploy up to 40 percent of its proceeds from the global offering for construction and upgrade of its manufacturing facility at Chuangmei Center. In addition to this, the company earmarked up to 10 percent of its proceeds for brand building initiatives.
During the last 24 months, Angelalign Technology successfully managed to reduceits production costs (impacted by significantly lowered unit lease cost of 3D printers used in manufacture) by leveraging on economies of scale and automated production lines.
In terms of the company’s different brands in its portfolio, its flagship brand ‘Angelalign’ continues to be the cynosure of all eyes (contributing 53% to the total annual revenue). Other brands targeted at younger segment as well as nighttime clear aligners (represented by Angelalign Kid and Comfos brands) contribute 23 percent and 20 percent to Angelalign’s annual revenue respectively.
To find out more about Angelalign Technology’s growth story, key financials and other relevant updates, please download our Research Report here. Please note that this feature is only available to registered site members.
コメント